K894541 is an FDA 510(k) clearance for the CARRINGTON DERMAL WOUND GEL. Classified as Dressing, Wound, Drug (product code FRO).
Submitted by Carrington Laboratories, Inc. (Dallas, US). The FDA issued a Cleared decision on November 30, 1989 after a review of 133 days - within the typical 510(k) review window.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.
View all Carrington Laboratories, Inc. devices